Lansforsakringar Fondforvaltning’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.7M Sell
393,771
-20,505
-5% -$1.83M 0.18% 96
2026
Q1
$29.8M Sell
414,276
-51
-0% -$3.93K 0.16% 116
2025
Q4
$32.9M Buy
414,327
+15,715
+4% +$1.24M 0.16% 113
2025
Q3
$30.1M Buy
398,612
+8,992
+2% +$616K 0.16% 120
2025
Q2
$26.9M Sell
389,620
-21,742
-5% -$1.43M 0.15% 119
2025
Q1
$27.9M Sell
411,362
-11,537
-3% -$690K 0.17% 112
2024
Q4
$19M Buy
+422,899
New +$23.7M 0.11% 163

Other funds holding CVS

Lansforsakringar Fondforvaltning's CVS Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning reduced its CVS Health (CVS) stake by 4.9% in Q2 2026, selling an estimated $1.83M and leaving 393,771 shares worth $40.7M. The position accounts for 0.18% of the portfolio, ranked #96.

Lansforsakringar Fondforvaltning first reported a position in CVS in Q4 2024 and has held it in 7 quarters since. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Lansforsakringar Fondforvaltning held 393,771 shares of CVS Health worth $40.7M as of Q2 2026.
  • Lansforsakringar Fondforvaltning sold 20,505 CVS Health shares in Q2 2026, an estimated $1.83M.
  • CVS Health made up 0.18% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #96 holding.
  • Lansforsakringar Fondforvaltning first reported a position in CVS Health in Q4 2024 and has held it in 7 quarters since.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.